NDC 50090-7372-01 - Metformin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-7372
- Requested NDC
- 50090-7372-01
- Package NDCs from labels
- 50090-7372-0, 50090-7372-1, 50090-7372-2, 50090-7372-3, 50090-7372-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-10-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metformin - A-S Medication Solutions | A-S Medication Solutions | 2024-10-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7372-0 | Metformin | 90 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 90 | 8 | |
| 50090-7372-1 | Metformin | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | 8 | |
| 50090-7372-2 | Metformin | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 8 | |
| 50090-7372-3 | Metformin | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-7372 | METFORMIN (METFORMIN ER 750 MG) TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS] | 8 | Current NDC, 4 package rows | 20241024_953404a4-0f03-42f1-8136-43238dad11f4.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7372-0 | EA - Each | 50090-7372 | c1ff5a44-97e5-4fde-a95d-16af2411c548 | 1 | 2024-12-10 |
| 50090-7372-1 | EA - Each | 50090-7372 | 1e733f22-8a11-455a-9fca-17d838f38cce | 1 | 2024-12-10 |
| 50090-7372-2 | EA - Each | 50090-7372 | 52259a9a-a462-4d32-bfa6-e07158dc6504 | 1 | 2024-12-10 |
| 50090-7372-3 | EA - Each | 50090-7372 | d4519f32-0d44-4b3d-b133-231c7a2bdb16 | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | REMEDYREPACK INC. | d5228e81-9c86-4781-b984-20feaa2ae779 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin | METFORMIN ER 500 MG | REMEDYREPACK INC. | 05999192-ebc6-4198-bd1e-f46abbfb4f8a | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | ANDA209313 860975 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 2a84c550-aed8-4058-961f-351a5e4cf7a1 | 2026-09-09 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Camber Pharmaceuticals, Inc. | 7cc02a26-5c22-445b-ad8f-3e7570c143d3 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | e6957674-86c1-4536-8e23-54ad7f2cacc4 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 1ed9dde4-339c-486f-a346-dde33a5e493f | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Lupin Pharmaceuticals, Inc. | 1200ea71-8a9e-4e49-bb77-7d9fe0d84ae7 | 2026-09-07 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin hydrochloride | METFORMIN HYDROCHLORIDE | Ajanta Pharma USA Inc. | 6d9179a8-9579-4804-a4c7-633f37aef1ee | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Granules India Ltd | 73197cb5-3e23-4ac0-b189-f9bc848bce66 | 2026-09-03 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | b6d7edc9-93d6-4480-906d-55c18d053600 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Dapagliflozin and Metformin hydrochloride | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 513bdf9f-774c-4f7f-935a-54d3885e80a4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Glumetza | METFORMIN HYDROCHLORIDE | Santarus, Inc. | fb832474-88d9-4e29-95cd-fbc446944cc4 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone Hydrochloride and Metformin Hydrochloride | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | Aurobindo Pharma Limited | 1fa2703e-fb73-44d5-aaa2-b12b1090d42c | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | Proficient Rx LP | d8bd1779-d1c4-4dde-816d-ea72b37bb5cd | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Pioglitazone HCL and Metformin HCL | PIOGLITAZONE HCL AND METFORMIN HCL | Torrent Pharmaceuticals Limited | 237d8fa2-633c-4c29-84d3-f1b413610dc3 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE | A-S Medication Solutions | 64f5b140-7ad8-4c07-bbfc-ae4618afa850 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Sitagliptin and Metformin Hydrochloride | SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | Sandoz Inc | a0fcdc08-0afc-4912-a126-3efea6bc8c61 | 2026-08-30 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Metformin Hydrochloride | METFORMIN HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ba0379cb-824e-4798-9ff9-99bcd1bea5cb | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| Synjardy | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Boehringer Ingelheim Pharmaceuticals, Inc. | 0fdd0255-0055-65f3-b2c0-db8fbb87beae | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
| alogliptin and metformin hydrochloride | ALOGLIPTIN AND METFORMIN HYDROCHLORIDE | Padagis Israel Pharmaceuticals Ltd | 14d98490-4f8f-4d2f-a4e9-7a3d7a0199ba | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 786Z46389E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.